Authors:
Gill, JK
Wang, LJ
Bretner, M
Newman, R
Kyprianou, N
Hosmane, RS
Citation: Jk. Gill et al., Potent in vitro anticancer activities of ring-expanded ("fat") nucleosidescontaining the imidazo[4,5-E][1,3]diazepine ring system, NUCLEOS NUC, 20(4-7), 2001, pp. 1043-1045
Authors:
Keledjian, K
Borkowski, A
Kim, G
Isaacs, JT
Jacobs, SC
Kyprianou, N
Citation: K. Keledjian et al., Reduction of human prostate tumor vascularity by the alpha 1-adrenoceptor antagonist terazosin, PROSTATE, 48(2), 2001, pp. 71-78
Authors:
Glassman, DT
Chon, JK
Borkowski, A
Jacobs, SC
Kyprianou, N
Citation: Dt. Glassman et al., Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor-beta expression in benign prostatic hyperplasia, PROSTATE, 46(1), 2001, pp. 45-51
Authors:
Szostak, MJ
Kaur, P
Amin, P
Jacobs, SC
Kyprianou, N
Citation: Mj. Szostak et al., Apoptosis and BCL-2 expression in prostate cancer: Significance in clinical outcome after brachytherapy, J UROL, 165(6), 2001, pp. 2126-2130
Citation: Em. Bruckheimer et N. Kyprianou, Dihydrotestosterone enhances transforming growth factor-ss-induced apoptosis in hormone-sensitive prostate cancer cells, ENDOCRINOL, 142(6), 2001, pp. 2419-2426
Citation: Mj. Szostak et N. Kyprianou, Radiation-induced apoptosis: Predictive and therapeutic significance in radiotherapy of prostate cancer (Review), ONCOL REP, 7(4), 2000, pp. 699-706
Citation: Em. Bruckheimer et N. Kyprianou, Apoptosis in prostate carcinogenesis - A growth regulator and a therapeutic target, CELL TIS RE, 301(1), 2000, pp. 153-162
Citation: N. Kyprianou et al., Effects of alpha(1)-adrenoceptor (alpha(1)-AR) antagonists on cell proliferation and apoptosis in the prostate: Therapeutic implications in prostaticdisease, PROSTATE, 2000, pp. 42-46
Authors:
Guo, YP
Sigman, DB
Borkowski, A
Kyprianou, N
Citation: Yp. Guo et al., Racial differences in prostate cancer growth: Apoptosis and cell proliferation in Caucasian and African-American patients, PROSTATE, 42(2), 2000, pp. 130-136
Citation: N. Kyprianou et al., Cell proliferation and apoptosis in prostate cancer: significance in disease progression and therapy, HIST HISTOP, 15(4), 2000, pp. 1211-1223
Citation: N. Kyprianou et Cm. Benning, Suppression of human prostate cancer cell growth by alpha 1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis, CANCER RES, 60(16), 2000, pp. 4550-4555
Citation: N. Kyprianou, Activation of TGF-beta signalling in human prostate cancer cells suppresses tumorigenicity via deregulation of cell cycle progression and induction of caspase-1 mediated apoptosis: significance in prostate tumorigenesis, PROSTATE C, 2, 1999, pp. S18-S18
Authors:
Chon, JK
Borkowski, A
Partin, AW
Isaacs, JT
Jacobs, SC
Kyprianou, N
Citation: Jk. Chon et al., alpha(1)-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia, J UROL, 161(6), 1999, pp. 2002-2008
Citation: Yp. Guo et N. Kyprianou, Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis, CANCER RES, 59(6), 1999, pp. 1366-1371
Authors:
Del Pizzo, JJ
Borkowski, A
Jacobs, SC
Kyprianou, N
Citation: Jj. Del Pizzo et al., Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival, AM J PATH, 155(4), 1999, pp. 1129-1136